Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2

Status

Active not recruiting 4Completed 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Other hematologic neoplasm 4Lymphoid 4

Conditions

Leukemia, Myeloid, Acute 34Leukemia, Lymphocytic, Chronic, B-Cell 26Myelodysplastic Syndromes 10Lymphoma, Mantle-Cell 8Neoplasms 7Leukemia, Myelomonocytic, Chronic 7Burkitt Lymphoma 7Recurrence 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Multiple Myeloma 5Lymphoma, Non-Hodgkin 5Lymphoma, Follicular 5Lymphoma, B-Cell, Marginal Zone 5Lymphoma, B-Cell 5Myeloproliferative Disorders 4Lymphoma, Large B-Cell, Diffuse 4Leukemia, Biphenotypic, Acute 4Leukemia, B-Cell 4Waldenstrom Macroglobulinemia 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Leukemia 3Primary Myelofibrosis 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma 2Hematologic Neoplasms 2Hematologic Diseases 2Thrombocytosis 1Thrombocythemia, Essential 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Polycythemia Vera 1

Interventions

venetoclax 4ibrutinib 4obinutuzumab 3fludarabine phosphate 3fludarabine 3Mesna 3Cyclophosphamide 3Whole-Body Irradiation 2Tacrolimus 2Peripheral Blood Stem Cell Transplantation 2Patient Reported Outcome Measures 2Mycophenolic Acid 2Melphalan 2Busulfan 2zanubrutinib 1ricolinostat 1idelalisib 1acalabrutinib 1Bone Marrow Transplantation 1Bendamustine Hydrochloride 1ARQ531 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Active not recruiting × Leukemia, B-Cell × venetoclax × Clear all
NCT04608318 2026-04-30

CLL17

German CLL Study Group

Phase 3 Active not recruiting
897 enrolled
LymphoidOther hematologic neoplasm

Leukemia, B-Cell

NCT03766763 2025-11-26

Preemptive Therapy for High Risk Chronic Lymphoid Leukemia Stage A

French Innovative Leukemia Organisation

Phase 2 Active not recruiting
82 enrolled
LymphoidOther hematologic neoplasm

Leukemia, B-Cell

NCT04515238 2025-06-10

CLL2-BZAG

German CLL Study Group

Phase 2 Active not recruiting
42 enrolled
LymphoidOther hematologic neoplasm

Leukemia, B-Cell

NCT03836261 2024-12-27

AMPLIFY

Acerta Pharma BV

Phase 3 Active not recruiting
984 enrolled 1 FDA
LymphoidOther hematologic neoplasm

Leukemia, Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡